209 related articles for article (PubMed ID: 31823505)
21. Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
Sandhya P; Kabeerdoss J; Christudoss P; Arulraj R; Mandal SK; Janardana R; Chebbi PP; Ganesan MP; Mahasampath G; Danda D
Int J Rheum Dis; 2022 Jan; 25(1):61-69. PubMed ID: 34791797
[TBL] [Abstract][Full Text] [Related]
22. [Serum IL-21 level in patients with primary Sjogren's syndrome and clinical significance of IL-21].
Yuan SL; Jiang L; Zhang XL; Li SF; Duan HM; Wang XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):124-6. PubMed ID: 17286904
[TBL] [Abstract][Full Text] [Related]
23. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
24. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
25. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?
Cinoku I; Mavragani CP; Tellis CC; Nezos A; Tselepis AD; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):61-67. PubMed ID: 30156537
[TBL] [Abstract][Full Text] [Related]
27. Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
Ben-Eli H; Solomon A; Aframian DJ; Ben-Chetrit E; Mevorach D; Kleinstern G; Waterboer T; Willhauck-Fleckenstein M; Pawlita M; Paltiel O
PLoS One; 2020; 15(12):e0244712. PubMed ID: 33382786
[TBL] [Abstract][Full Text] [Related]
28. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
29. Serum cystatin C is not an appropriate marker for kidney involvement in patients with primary Sjögren's syndrome.
Altunoğlu A; Erten Ş; Şahin A; Işıkoğlu S; Neşelioğlu S; Erzurum C; Erel Ö
Int J Rheum Dis; 2017 Mar; 20(3):371-375. PubMed ID: 25367815
[TBL] [Abstract][Full Text] [Related]
30. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
[TBL] [Abstract][Full Text] [Related]
31. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
He J; Fang W; Li ZG
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
[TBL] [Abstract][Full Text] [Related]
32. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
33. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
34. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
35. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sjögren's syndrome.
Qin Q; Wang H; Wang HZ; Huang YL; Li H; Zhang WW; Zhang JR; He LL; Xia R; Zhao DB; Deng AM
Mod Rheumatol; 2014 Sep; 24(5):793-7. PubMed ID: 24372293
[TBL] [Abstract][Full Text] [Related]
37. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
38. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
[TBL] [Abstract][Full Text] [Related]
39. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
40. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.
Pourmand N; Wahren-Herlenius M; Gunnarsson I; Svenungsson E; Löfström B; Ioannou Y; Isenberg DA; Magnusson CG
Ann Rheum Dis; 1999 Oct; 58(10):623-9. PubMed ID: 10491361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
